Paper36940609
The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus.
Puhl AC and 5 others. Bioorg Med Chem, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus. Papers, record 36940609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36940609
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chikungunya Fever | Major topic |
| Chikungunya virus | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Antiviral Agents | |
| Caco-2 Cells | |
| Protein Disulfide-Isomerases | |
| Virus Replication | |
| Flavins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K05 AT001585 | NCCIH NIH HHS | United States | K05AT001585 | PubMed | NIH RePORTER |
| R43 AT010585 | NCCIH NIH HHS | United States | R43AT010585 | PubMed and NIH | NIH RePORTER |
| R44 GM122196 | NIGMS NIH HHS | United States | R44GM122196 | PubMed and NIH | NIH RePORTER |
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34056242 | Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation. | ACS Omega | 2021 | https://conductscience.org/library/papers/34056242 | PubMed |
| 2 | 22988091 | Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22988091 | PubMed |
| 3 | 36269563 | Machine Learning Models Identify New Inhibitors for Human OATP1B1. | Mol Pharm | 2022 | https://conductscience.org/library/papers/36269563 | PubMed |
| 4 | 32928738 | Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32928738 | PubMed |
| 6 | 21121641 | Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120. | ACS Chem Biol | 2011 | https://conductscience.org/library/papers/21121641 | PubMed |
| 7 | 23403423 | A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23403423 | PubMed |
| 8 | 33835811 | Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors. | J Med Chem | 2021 | https://conductscience.org/library/papers/33835811 | PubMed |
| 9 | 28288924 | Global expansion of chikungunya virus: mapping the 64-year history. | Int J Infect Dis | 2017 | https://conductscience.org/library/papers/28288924 | PubMed |
| 10 | 19559054 | Assay development and high-throughput antiviral drug screening against Bluetongue virus. | Antiviral Res | 2009 | https://conductscience.org/library/papers/19559054 | PubMed |
| 11 | 36239304 | Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika. | J Chem Inf Model | 2022 | https://conductscience.org/library/papers/36239304 | PubMed |
| 12 | 26159730 | Chikungunya virus pathogenesis: From bedside to bench. | Antiviral Res | 2015 | https://conductscience.org/library/papers/26159730 | PubMed |
| 13 | 35301150 | Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds. | Drug Discov Today | 2022 | https://conductscience.org/library/papers/35301150 | PubMed |
| 14 | 32340991 | Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32340991 | PubMed |
| 15 | 23151166 | Chikungunya virus and prospects for a vaccine. | Expert Rev Vaccines | 2012 | https://conductscience.org/library/papers/23151166 | PubMed |
| 16 | 31751347 | Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection. | PLoS Negl Trop Dis | 2019 | https://conductscience.org/library/papers/31751347 | PubMed |
| 17 | 29454041 | Potential risks of Zika and chikungunya outbreaks in Brazil: A modeling study. | Int J Infect Dis | 2018 | https://conductscience.org/library/papers/29454041 | PubMed |
| 18 | 35891332 | The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication. | Viruses | 2022 | https://conductscience.org/library/papers/35891332 | PubMed |
| 19 | 28461071 | Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential. | Antiviral Res | 2017 | https://conductscience.org/library/papers/28461071 | PubMed |
| 20 | 34964633 | Machine Learning Models for Mycobacterium tuberculosisIn Vitro Activity: Prediction and Target Visualization. | Mol Pharm | 2022 | https://conductscience.org/library/papers/34964633 | PubMed |
| 21 | 34372513 | Antivirals against the Chikungunya Virus. | Viruses | 2021 | https://conductscience.org/library/papers/34372513 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42787651 | Workflow for Accurate Measurement of PDI Reductase Kinetics Using a Fluorescent Disulfide Substrate. | MicroPubl Biol | 2026 | https://conductscience.org/library/papers/42787651 | PubMed |
| 42368589 | Recent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368589 | PubMed |
| 40007016 | Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures. | Viruses | 2025 | https://conductscience.org/library/papers/40007016 | PubMed |
| 39193780 | Pathogenicity and virulence of chikungunya virus. | Virulence | 2024 | https://conductscience.org/library/papers/39193780 | PubMed |
| 38910486 | Advances in the Development of Non-Structural Protein 1 (NsP1) Inhibitors for the Treatment of Chikungunya Virus Infection. | Mini Rev Med Chem | 2024 | https://conductscience.org/library/papers/38910486 | PubMed |
| 37482237 | Learning from COVID-19: How drug hunters can prepare for the next pandemic. | Drug Discov Today | 2023 | https://conductscience.org/library/papers/37482237 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| CALM1 | 801 | PubTator's text mining | https://conductscience.org/library/genes/801 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| P4HB | 5034 | PubTator's text mining | https://conductscience.org/library/genes/5034 | NCBI Gene |
| PPIG | 9360 | PubTator's text mining | https://conductscience.org/library/genes/9360 | NCBI Gene |
| PRDX5 | 25824 | PubTator's text mining | https://conductscience.org/library/genes/25824 | NCBI Gene |
| SH2D3A | 10045 | PubTator's text mining | https://conductscience.org/library/genes/10045 | NCBI Gene |
| TDP2 | 51567 | PubTator's text mining | https://conductscience.org/library/genes/51567 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36940609
GET https://conductscience.org/api/papers/v1/36940609/references?page=2